FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028192160> ?p ?o ?g. }

• W2028192160 endingPage "85" @default.
• W2028192160 startingPage "73" @default.
• W2028192160 abstract "Previous research indicated that 5-HT3 antagonists can reduce ethanol drinking in rats, but drinking conditions and other environmental manipulations influenced the efficacy of these antagonists. The current experiments were conducted to examine the effects of the 5-HT3 antagonists MDL 72222 (MDL) or ICS 205-930 (ICS) on 24-h ethanol (10% v/v) consumption during acquisition, maintenance, and following a period of deprivation in selectively bred high alcohol-preferring (P) male rats. In an analysis of the acquisition of ethanol consumption, daily injections of MDL (1 mg/kg; s.c.) or ICS (1 or 5 mg/kg) were administered to separate groups of P rats during the initial 10 days of ethanol exposure. To examine the maintenance of ethanol drinking, these same groups of rats were allowed access to ethanol for 21 days with no pharmacological manipulations, and were then administered either saline or the 5-HT3 antagonist. To examine the effects of a 5-HT3 antagonist on relapse of ethanol drinking, another group of P rats was allowed access to ethanol for 6 weeks and was then deprived of ethanol for 3 weeks. Prior to ethanol reinstatement, rats were treated chronically (seven daily injections) or acutely with MDL (1 mg/kg), saline, or received no injections. MDL (1 mg/kg) and ICS (1 or 5 mg/kg) reduced ethanol intake during acquisition (60–80%) and during maintenance drinking (35–70%) in P rats pretreated with saline during acquisition. However, in rats pretreated with MDL or ICS during acquisition, there was a significant reduction in the effectiveness of either MDL or ICS to reduce ongoing ethanol drinking. Neither acute nor chronic treatment with 1 mg/kg MDL altered the 80% increase in ethanol consumption observed on the first day of reinstatement following a 3-week deprivation period. However, in a follow-up study, acute treatment with MDL (3 mg/kg) or ICS (5 mg/kg) did prevent the 80% increase in ethanol consumption observed on the first day of reinstatement. Overall, the results suggest that 5-HT3 receptors are involved in the acquisition and maintenance of 24-h ethanol drinking, and that neuroadaptations may occur as a result of chronic treatment with 5-HT3 antagonists, or during prolonged alcohol deprivation, which alter the involvement of these receptors in regulating alcohol drinking in the P rat." @default.
• W2028192160 created "2016-06-24" @default.
• W2028192160 creator A5017242154 @default.
• W2028192160 creator A5023854910 @default.
• W2028192160 creator A5029275926 @default.
• W2028192160 creator A5036789705 @default.
• W2028192160 creator A5057738611 @default.
• W2028192160 creator A5074035943 @default.
• W2028192160 creator A5076405210 @default.
• W2028192160 creator A5088726928 @default.
• W2028192160 date "2000-05-01" @default.
• W2028192160 modified "2023-10-12" @default.
• W2028192160 title "Effects of 5-HT3 receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats" @default.
• W2028192160 cites W1969181676 @default.
• W2028192160 cites W1972687616 @default.
• W2028192160 cites W1973066695 @default.
• W2028192160 cites W1973775860 @default.
• W2028192160 cites W1979331157 @default.
• W2028192160 cites W1991671180 @default.
• W2028192160 cites W1994093302 @default.
• W2028192160 cites W1998757791 @default.
• W2028192160 cites W1999407810 @default.
• W2028192160 cites W2000275624 @default.
• W2028192160 cites W2009679260 @default.
• W2028192160 cites W2013907526 @default.
• W2028192160 cites W2016873572 @default.
• W2028192160 cites W2018284650 @default.
• W2028192160 cites W2026723434 @default.
• W2028192160 cites W2033122986 @default.
• W2028192160 cites W2034387660 @default.
• W2028192160 cites W2064323618 @default.
• W2028192160 cites W2064533425 @default.
• W2028192160 cites W2070325433 @default.
• W2028192160 cites W2072830432 @default.
• W2028192160 cites W2076797176 @default.
• W2028192160 cites W2078119240 @default.
• W2028192160 cites W2089736075 @default.
• W2028192160 cites W2150602253 @default.
• W2028192160 cites W2153866192 @default.
• W2028192160 cites W2162565570 @default.
• W2028192160 cites W9321131 @default.
• W2028192160 doi "https://doi.org/10.1016/s0741-8329(00)00083-5" @default.
• W2028192160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10946160" @default.
• W2028192160 hasPublicationYear "2000" @default.
• W2028192160 type Work @default.
• W2028192160 sameAs 2028192160 @default.
• W2028192160 citedByCount "67" @default.
• W2028192160 countsByYear W20281921602012 @default.
• W2028192160 countsByYear W20281921602013 @default.
• W2028192160 countsByYear W20281921602014 @default.
• W2028192160 countsByYear W20281921602015 @default.
• W2028192160 countsByYear W20281921602016 @default.
• W2028192160 countsByYear W20281921602017 @default.
• W2028192160 countsByYear W20281921602020 @default.
• W2028192160 crossrefType "journal-article" @default.
• W2028192160 hasAuthorship W2028192160A5017242154 @default.
• W2028192160 hasAuthorship W2028192160A5023854910 @default.
• W2028192160 hasAuthorship W2028192160A5029275926 @default.
• W2028192160 hasAuthorship W2028192160A5036789705 @default.
• W2028192160 hasAuthorship W2028192160A5057738611 @default.
• W2028192160 hasAuthorship W2028192160A5074035943 @default.
• W2028192160 hasAuthorship W2028192160A5076405210 @default.
• W2028192160 hasAuthorship W2028192160A5088726928 @default.
• W2028192160 hasConcept C126322002 @default.
• W2028192160 hasConcept C134018914 @default.
• W2028192160 hasConcept C170493617 @default.
• W2028192160 hasConcept C185592680 @default.
• W2028192160 hasConcept C2776885963 @default.
• W2028192160 hasConcept C2777397205 @default.
• W2028192160 hasConcept C2780161600 @default.
• W2028192160 hasConcept C2781066024 @default.
• W2028192160 hasConcept C55493867 @default.
• W2028192160 hasConcept C71924100 @default.
• W2028192160 hasConcept C98274493 @default.
• W2028192160 hasConceptScore W2028192160C126322002 @default.
• W2028192160 hasConceptScore W2028192160C134018914 @default.
• W2028192160 hasConceptScore W2028192160C170493617 @default.
• W2028192160 hasConceptScore W2028192160C185592680 @default.
• W2028192160 hasConceptScore W2028192160C2776885963 @default.
• W2028192160 hasConceptScore W2028192160C2777397205 @default.
• W2028192160 hasConceptScore W2028192160C2780161600 @default.
• W2028192160 hasConceptScore W2028192160C2781066024 @default.
• W2028192160 hasConceptScore W2028192160C55493867 @default.
• W2028192160 hasConceptScore W2028192160C71924100 @default.
• W2028192160 hasConceptScore W2028192160C98274493 @default.
• W2028192160 hasIssue "1" @default.
• W2028192160 hasLocation W20281921601 @default.
• W2028192160 hasLocation W20281921602 @default.
• W2028192160 hasOpenAccess W2028192160 @default.
• W2028192160 hasPrimaryLocation W20281921601 @default.
• W2028192160 hasRelatedWork W140851365 @default.
• W2028192160 hasRelatedWork W2000490990 @default.
• W2028192160 hasRelatedWork W2028944838 @default.
• W2028192160 hasRelatedWork W2074052481 @default.
• W2028192160 hasRelatedWork W2088249402 @default.
• W2028192160 hasRelatedWork W2370126060 @default.
• W2028192160 hasRelatedWork W2373611490 @default.
• W2028192160 hasRelatedWork W2418100112 @default.

• next